MEDICAL CHANNEL ASIA

PUBLIC PORTAL

PUBLIC PORTAL

MEDICALLY REVIEWED

Finerenone (Kerendia) – A new therapeutic agent in the Diabetic Kidney Disease (DKD) treatment paradigm

finerenone (Kerendia) diabetic kidney disease

The Burden of Diabetic Kidney Disease
Diabetes is the leading cause of kidney failure in Singapore, accounting for 66% of newly diagnosed ESRD in 2015. There are 400,000 diabetics in Singapore today and the country Sign Up or Log In as a healthcare professional to read the full article.

Share via

Also worth reading

People also read: